
|Videos|April 29, 2020
CAR T-Cell Therapy During the COVID-19 Pandemic
Advertisement
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Advertisement
Advertisement
Trending on CGTlive®
1
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
2
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
3
Guess the Therapy Answer October 16, 2025
4
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
5